Helio Corporation shareholders approve reverse stock split to facilitate exchange uplisting

Helio Corp /FL/

Written consent from holders of 64.44% of shares (16.33M of 25.34M) approving reverse split at ratio of 1.25:1 to 5:1.
Three majority shareholders: Gregory Delory (22.10%), Paul Turin (30.50%), Edward Cabrera (11.84%).
Board to determine exact ratio and timing within 12 months; split intended to meet $4.00 minimum bid price for Nasdaq or NYSE listing.
Company also plans an underwritten public offering in conjunction with the uplisting.
Fractional shares will be rounded up to nearest whole share or paid in cash.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Helio Corp /FL/ shareholders approved Amendment to the Articles of Incorporation to effect a reverse stock split of the Company's issued and outstanding Common Stock at a ratio within the range of 1.25-for-1 to 5-for-1, with the exact ratio and timing to be determined by the Board of Directors at the 2026-05-11 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2026-05-11

Exact text from the filing

By the Written Consent, the majority shareholders approved and authorized an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the Company’s issued and outstanding Common Stock (the “ Reverse Stock Split ”) at a ratio within the range of 1.25-for-1 to 5-for-1, with the exact ratio and timing to be determined by the Board of Directors (or a duly authorized committee thereof) in its sole discretion at any time within 12 months following the date of the Written Consent.

View on SEC.gov

Browse all shareholder votes →

Helio Corp /FL/ filing history →

Source: SEC EDGAR

accession 0001213900-26-057683

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.